503b semaglutide outsourcing facility The FDA has strictly clarified that with the national supply of GLP-1 medications stabilizing, compounders can no longer produce "essentially copies" of FDA-approved drugs. Enforcement discretion periods for FDA moves to remove GLP-1

CMS delays Part D GLP-1 model amid skepticism from insurers. April 21, 2026

When you take them together, you are essentially building a stronger house (collagen) while also installing a high-end security system to prevent damage (glutathione)

[9] If there is a nutritional deficiency underlying the condition, various other signs and symptoms such as glossitis (swollen tongue) may be present

Besides the contraindicated populations weve discussed in the previous safety section, berberine is likely not to be a suitable supplemental intervention for anyone seeking: Dramatic weight loss: Although berberine appears to have weight-reducing potential,32 33 it isnt the natures Ozempic that some of the marketing might have you believe.62 If you experience any weight loss on berberine, it will be through roundabout mechanisms and much more modest than what you can expect with something like a GLP-1 receptor agonist

In that environment, the company with the strongest portfolio gains a durable advantage, and that advantage is increasingly shifting toward Eli Lilly